Role of Smartphone Applications in Blood Pressure Medication Adherence

Introduction to High Blood Pressure

A recent study published in JAMA Internal Medicine highlights the potential of a smartphone application in enhancing patients’ adherence to blood pressure medications. High blood pressure, which affects over one-third of adults in the United States, is estimated to be the underlying cause of more than 73,000 deaths annually. Effective management of high blood pressure is crucial in reducing the risk of cardiovascular diseases.

Treatment Strategies for High Blood Pressure

Various approaches have been explored to treat high blood pressure, ranging from lifestyle changes to a variety of medications. Current treatment options include different classes of blood pressure medications. However, regardless of the medication type, adherence to prescribed treatments is a critical factor for successful management.

Challenges of Medication Adherence

Research indicates that more than 50% of patients identified as having “medication-resistant” high blood pressure do not follow their prescribed medication regimen. To combat this issue, numerous strategies have been implemented to improve medication adherence, with mobile health interventions emerging as a promising solution.

The Medisafe Smartphone Application Trial

A recent clinical trial, detailed in JAMA Internal Medicine, assessed the effectiveness of the Medisafe smartphone application on self-reported medication adherence and blood pressure control. The trial, named The Medication Adherence Improvement Support App for Engagement Blood Pressure (MedISAFE-BP), was conducted in the United States.

Study Design and Methodology

In this study, researchers randomly divided participants into two groups: the intervention group and the control group. Those in the intervention group utilized the Medisafe application, which provides reminder alerts, adherence reports, and optional peer support, while the control group did not use the app.

Outcomes were measured using the Morisky Medication Adherence Scale (MMAS), which ranges from 0 to 8, with lower scores indicating poorer adherence to medication.

Findings and Conclusions

After a 12-week follow-up, results indicated that participants using the Medisafe application experienced an improvement in MMAS scores by 0.4. Conversely, the control group did not show any enhancements in medication adherence. The change in systolic blood pressure for both groups was not statistically significant.

In light of these findings, the authors concluded that while the smartphone application led to a minor improvement in self-reported medication adherence, it had a negligible effect on systolic blood pressure.

Additional Relevant Topics

– Nitrate-rich Vegetables and the Lowering of Blood Pressure Myth
– Can Dementia Be Prevented with Stricter Blood Pressure Control?
– Ambulatory Blood Pressure Monitoring May Help Prevent Premature Deaths
– Developers Test New Blood Pressure App for iPhone
– Southern Diet Plays a Large Role in the Risk of High Blood Pressure

Reference

Morawski, K., Ghazinouri, R., Krumme, A., Lauffenburger, J. C., Lu, Z., Durfee, E., … & Juusola, J. L. (2018). Association of a smartphone application with medication adherence and blood pressure control: the MedISAFE-BP randomized clinical trial. JAMA Internal Medicine.

Disclaimer

This is not a sponsored post. The application, nor anyone affiliated with this application, is not in any way connected to Medical News Bulletin.